Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer

This publication has 78 references indexed in Scilit:

• ADAM10 Activation Is Required for Green Tea (–)-Epigallocatechin-3-gallate-induced α-Secretase Cleavage of Amyloid Precursor Protein
  Journal of Biological Chemistry, 2006
• Treatment of epigallocatechin‐3‐gallate inhibits matrix metalloproteinases‐2 and ‐9 via inhibition of activation of mitogen‐activated protein kinases, c‐jun and NF‐κB in human prostate carcinoma DU‐145 cells
  The Prostate, 2003
• Modulation of phosphatidylinositol‐3‐kinase/protein kinase B‐ and mitogen‐activated protein kinase‐pathways by tea polyphenols in human prostate cancer cells
  Journal of Cellular Biochemistry, 2003
• Green tea and risk of breast cancer in Asian Americans
  International Journal of Cancer, 2003
• Estrogen Receptor-Mediated Actions of Polyphenolic Catechins in Vivo and in Vitro
  Toxicological Sciences, 2002
• The green tea polyphenol (−)-epigallocatechin gallate attenuates β-amyloid-induced neurotoxicity in cultured hippocampal neurons
  Life Sciences, 2001
• Growth Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Green Tea Constituent (-)-Epigallocatechin-3-gallate in Androgen-Sensitive and Androgen-Insensitive Human Prostate Carcinoma Cells
  Toxicology and Applied Pharmacology, 2000
• Mechanisms of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and cip and INK4 inhibitors
  Journal of Molecular Biology, 1999
• Green Tea Constituent Epigallocatechin-3-Gallate and Induction of Apoptosis and Cell Cycle Arrest in Human Carcinoma Cells
  JNCI Journal of the National Cancer Institute, 1997
• Effects of green tea catechins on the progression or late promotion stage of mammary gland carcinogenesis in female Sprague-Dawley rats pretreated with 7,12-dimethylbenz(a)anthracene
  Cancer Letters, 1997